Metraipolis › archive › dc_f46eb8bbb0ca

Synergistic Cancer Metabolic Therapy via Co-Delivery of 3-Bromopyruvate and Temozolomide with a Supramolecular Shuttle — Europe PMC PMID:41124053

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41124053
DOI: 10.1021/acsami.5c17607
License (as archived): solo-consultazione
Archived: 2026-11-09T03:48:21.391Z
SHA-256 of the archived text: 1a9b7c4520c4772319c83f7fccb968ada17ebd4cd88f5bed431b17c9d763f861
Stable URL of this page: https://metraipolis.com/documento/dc_f46eb8bbb0ca

How to cite

Synergistic Cancer Metabolic Therapy via Co-Delivery of 3-Bromopyruvate and Temozolomide with a Supramolecular Shuttle — Europe PMC PMID:41124053 — Europe PMC (en), https://europepmc.org/article/MED/41124053 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f46eb8bbb0ca (Metraipolis archive dc_f46eb8bbb0ca, sha256 1a9b7c4520c4772319c83f7fccb968ada17ebd4cd88f5bed431b17c9d763f861)

BibTeX

@misc{dcf46eb8bbb0ca,
  title = {Synergistic Cancer Metabolic Therapy via Co-Delivery of 3-Bromopyruvate and Temozolomide with a Supramolecular Shuttle — Europe PMC PMID:41124053},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41124053},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f46eb8bbb0ca; sha256 1a9b7c4520c4772319c83f7fccb968ada17ebd4cd88f5bed431b17c9d763f861},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41124053. Agents can read the archived copy with the MCP tool read_document.